- Home
- Medical news & Guidelines- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
 
- Health news
- Fact Check- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
 
- AYUSH
- State News- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
 
- Medical Education
- Industry
Thermo Fisher Scientific inaugurates expanded RnD Centre of Excellence in Bengaluru

Bengaluru: Thermo Fisher Scientific has inaugurated its expanded Research and Development (R&D) Centre of Excellence in Bengaluru.
The facility, spanning 37,000 sq. ft, is dedicated to pioneering advances in antibody design, development, and manufacturing. It was inaugurated on October 27 by Sanjeev Kumar Gupta, CEO of the Karnataka Digital Economy Mission (KDEM).
“Thermo Fisher has invested over Rs 160 crores in this expansion, reinforcing its long-term commitment to India’s research ecosystem. The expanded 37,000 sq. ft. facility incorporates advanced automation and analytical platforms to support immunoassays, protein analysis, and cell-based studies," the company said in a statement to PTI.
Thermo Fisher, said the expansion will create 100 plus jobs in the coming years, strengthening local talent development and contributing to Karnataka’s thriving life sciences ecosystem.
“It represents a significant milestone in the company’s efforts to accelerate innovation and scientific collaboration from India,” it stated.
Speaking about the occasion, Minister for Electronics, IT and Biotechnology Priyank Kharge said, “Karnataka has long positioned itself as a vibrant hub for biotechnology and life sciences. The expansion of Thermo Fisher’s facility is a testament to the state’s continued emphasis of this objective.”
“Through our Karnataka Biotechnology Mission and aligned state policies, we are enabling innovation, nurturing talent, and facilitating collaboration between government, academia and industry. This facility strengthens the state’s capability to contribute meaningfully to India’s broader biotechnology vision,” he added.
According to the Thermo Fisher Scientific Inc, it is the world leader in serving science, with annual revenue over USD 40 billion.
Thermo Fisher operates a global sterile fill-finish manufacturing network and now adds Ridgefield to its U.S. sites in Greenville, North Carolina and Plainville, Massachusetts. Its global team delivers an unrivaled combination of technologies, purchasing convenience and pharmaceutical services through its brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
Read also: Thermo Fisher Scientific concludes acquisition of Sanofi New Jersey site
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751






